A detailed history of Manchester Capital Management LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Manchester Capital Management LLC holds 57 shares of DGX stock, worth $7,802. This represents 0.0% of its overall portfolio holdings.

Number of Shares
57
Previous 35 62.86%
Holding current value
$7,802
Previous $4,000 75.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$123.78 - $142.11 $2,723 - $3,126
22 Added 62.86%
57 $7,000
Q4 2023

Feb 08, 2024

SELL
$120.62 - $141.12 $964 - $1,128
-8 Reduced 18.6%
35 $4,000
Q3 2023

Nov 09, 2023

BUY
$121.86 - $144.92 $2,071 - $2,463
17 Added 65.38%
43 $5,000
Q2 2023

Aug 14, 2023

BUY
$130.56 - $146.84 $1,958 - $2,202
15 Added 136.36%
26 $3,000
Q1 2023

May 09, 2023

BUY
$131.53 - $155.76 $1,052 - $1,246
8 Added 266.67%
11 $1,000
Q4 2022

Feb 09, 2023

BUY
$123.31 - $157.26 $369 - $471
3 New
3 $0
Q2 2022

Aug 10, 2022

SELL
$127.07 - $145.39 $381 - $436
-3 Closed
0 $0
Q1 2022

May 09, 2022

SELL
$129.09 - $164.35 $516 - $657
-4 Reduced 57.14%
3 $0
Q4 2021

Feb 10, 2022

SELL
$140.36 - $173.01 $561 - $692
-4 Reduced 36.36%
7 $1,000
Q3 2021

Nov 12, 2021

SELL
$132.95 - $158.0 $11,832 - $14,062
-89 Reduced 89.0%
11 $2,000
Q1 2021

May 13, 2021

BUY
$114.63 - $133.34 $11,463 - $13,334
100 New
100 $13,000
Q3 2020

Oct 27, 2020

SELL
$107.05 - $130.01 $26,762 - $32,502
-250 Closed
0 $0
Q2 2018

Aug 08, 2018

SELL
$97.35 - $113.14 $6,522 - $7,580
-67 Reduced 21.14%
250 $27,000
Q1 2018

May 07, 2018

BUY
$96.42 - $107.88 $6,460 - $7,227
67 Added 26.8%
317 $32,000
Q3 2017

Nov 09, 2017

BUY
$91.96 - $108.35 $22,990 - $27,087
250
250 $23,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Manchester Capital Management LLC Portfolio

Follow Manchester Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manchester Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manchester Capital Management LLC with notifications on news.